1 |
SCHERING CORPORATION v. MYLAN PHARMACEUTICAL |
2:00-cv-01657 |
D.N.J. |
|
|
|
|
2 |
Geneva Pharm., et al v. Mylan Pharmaceutical |
1:00-cv-06449 |
S.D.N.Y. |
|
|
|
|
3 |
Geneva Pharm., et al v. Mylan Pharmaceutical |
1:00-cv-06449 |
S.D.N.Y. |
|
|
|
|
4 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
5 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
6 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
7 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
8 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
9 |
ASTRAZENECA UK LTD, et al v. MYLAN PHARMACEUTICAL |
2:00-cv-02239 |
W.D.Pa. |
|
|
|
|
10 |
ASTRAZENECA UK LTD, et al v. MYLAN PHARMACEUTICAL |
2:00-cv-02239 |
W.D.Pa. |
|
|
|
|
11 |
Bristol-Myers Squibb v. Mylan Pharmaceut., et al |
1:01-cv-00414 |
S.D.N.Y. |
|
|
|
|
12 |
ORGANON INC., et al v. MYLAN PHARMACEUTICAL |
2:01-cv-03835 |
D.N.J. |
|
|
|
|
13 |
ORGANON INC., et al v. MYLAN PHARMACEUTICAL |
2:01-cv-03835 |
D.N.J. |
|
|
|
|
14 |
ALZA CORPORATION, et al v. MYLAN LABORATORIES, et al |
2:02-cv-00230 |
W.D.Pa. |
|
|
|
|
15 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00020 |
D.Vt. |
|
|
|
|
16 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00020 |
D.Vt. |
|
|
|
|
17 |
ALZA CORPORATION, et al v. MYLAN LABORATORIES, et al |
2:02-cv-00230 |
W.D.Pa. |
|
|
|
|
18 |
Ortho-McNeil Pharm., et al v. Mylan Laboratories, et al |
1:02-cv-00032 |
N.D.W.Va. |
|
|
|
|
19 |
Ortho-McNeil Pharm., et al v. Mylan Laboratories, et al |
1:02-cv-00032 |
N.D.W.Va. |
|
|
|
|
20 |
Ortho-McNeil Pharm., et al v. Mylan Laboratories, et al |
1:02-cv-00032 |
N.D.W.Va. |
|
|
|
|
21 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00213 |
D.Vt. |
|
|
|
|
22 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00213 |
D.Vt. |
|
|
|
|
23 |
Merck & Co., Inc. v. Mylan Pharmaceutical |
1:03-cv-01953 |
S.D.N.Y. |
|
|
|
|
24 |
CEPHALON, INC. v. MYLAN PHARMACEUTICAL, et al |
2:03-cv-01394 |
D.N.J. |
|
|
|
|
25 |
KREMERS URBAN DEVELOPMENT COMPANY et al v. ESTEVE QUIMICA, S.A. et al |
1:03-cv-01684 |
D.D.C. |
|
- 8 Product company
- 9 Individual
|
|
|
26 |
KREMERS URBAN DEVELOPMENT COMPANY et al v. ESTEVE QUIMICA, S.A. et al |
1:03-cv-01684 |
D.D.C. |
|
- 8 Product company
- 9 Individual
|
|
|
27 |
JANSSEN PHARMACEUTIC, et al v. MYLAN PHARMACEUTICAL |
2:03-cv-06220 |
D.N.J. |
|
|
|
|
28 |
JANSSEN PHARMACEUTIC, et al v. MYLAN PHARMACEUTICAL |
2:03-cv-06220 |
D.N.J. |
|
|
|
|
29 |
Boehringer Ingelheim International GMBH et al v. Mylan Pharmaceuticals Inc. |
1:05-cv-00854 |
D.Del. |
|
|
|
|
30 |
Boehringer Ingelheim International GMBH et al v. Mylan Pharmaceuticals Inc. |
1:05-cv-00854 |
D.Del. |
|
|
|
|
31 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. MYLAN PHARMACEUTICALS,INC. |
2:07-cv-04214 |
D.N.J. |
|
|
|
|
32 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. MYLAN PHARMACEUTICALS,INC. |
2:07-cv-04214 |
D.N.J. |
|
|
|
|
33 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. MYLAN PHARMACEUTICALS,INC. |
2:07-cv-04214 |
D.N.J. |
|
|
|
|
34 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. MYLAN PHARMACEUTICALS,INC. |
2:07-cv-04214 |
D.N.J. |
|
|
|
|
35 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-04918 |
D.N.J. |
|
|
|
|
36 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-04918 |
D.N.J. |
|
|
|
|
37 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-04918 |
D.N.J. |
|
|
|
|
38 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-05930 |
D.N.J. |
|
|
|
|
39 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-05930 |
D.N.J. |
|
|
|
|
40 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-05930 |
D.N.J. |
|
|
|
|
41 |
Sciele Pharma Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:07-cv-00818 |
D.Del. |
|
|
|
|
42 |
Sciele Pharma Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:07-cv-00818 |
D.Del. |
|
|
|
|
43 |
Ortho-McNeil Pharmaceutical, Inc. v. Mylan Pharmaceuticals, Inc. et al |
1:08-cv-00101 |
N.D.W.Va. |
|
|
|
|
44 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
45 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
46 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
47 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
48 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
49 |
SCHERING CORPORATION v. MYLAN PHARMACEUTICALS INC. |
3:09-cv-00874 |
D.N.J. |
|
|
|
|
50 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|